ProShare Advisors’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.5K | Sell |
18,089
-962
| -5% | -$3.59K | ﹤0.01% | 1949 |
|
|
2025
Q1 | $52.6K | Sell |
19,051
-4,770
| -20% | -$13.2K | ﹤0.01% | 1952 |
|
|
2024
Q4 | $132K | Buy |
23,821
+8,784
| +58% | +$48.7K | ﹤0.01% | 2009 |
|
|
2024
Q3 | $125K | Buy |
+15,037
| New | +$125K | ﹤0.01% | 1846 |
|
|
2024
Q2 | – | Sell |
-12,121
| Closed | -$79.5K | – | 2002 |
|
|
2024
Q1 | $79.5K | Buy |
12,121
+1,079
| +10% | +$7.08K | ﹤0.01% | 1855 |
|
|
2023
Q4 | $71.7K | Buy |
+11,042
| New | +$71.7K | ﹤0.01% | 1822 |
|